Clinical Trials List
Protocol NumberIHN01
2011-09-01 - 2016-09-01
Phase III
Terminated1
-
Sponsor
-
Trial scale
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Ling-Wei Wang Division of Hematology & Oncology
- 許彥彬 Division of Otolaryngology
- 羅文良 Division of Oral and Maxillofacial Surgery
- 黃品逸 Division of Radiation Therapy
- 高壽延 Division of Oral and Maxillofacial Surgery
- Muh-Hwa Yang Division of Hematology & Oncology
- 王怡芬 Division of Otolaryngology
- 吳政憲 Division of Oral and Maxillofacial Surgery
- 戴世光 Division of Otolaryngology
- 陳雅薇 Division of Oral and Maxillofacial Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
200 participants
-
Global
710 participants
